Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGUS Fro…

Insights from 2023 ASH Annual Meeting

R. Banerjee

Should Patients With High-Risk SMM Be Treated Outside a Clinical Tri…

Scripps Health

M. Gertz

Key Myeloma & MGUS Updates From ASH

Memorial Sloan Kettering Cancer Center

S. Mailankody

Smoldering Myeloma: If and When to Treat

Victor Jimenez Zepeda

Management of Smoldering Myeloma

XV Eurasian Hematology-Oncology Congress - EHOC 2024

C. Cerchione

ASH 2024 Insights: Cilta-Cel CAR-T in High-Risk SMM - Results From C…

2024 ASH Annual Meeting Insights Hub

O. Nadeem

Why We Should Not Treat SMM

PleXus Communications

B. Derman

ASH 2023 Insights: "CENTAURUS Study Final Analysis - Efficacy & Safe…

Insights from 2023 ASH Annual Meeting

O. Landgren

Oncologists' Guidance on Treating Smoldering Myeloma: Panel Discussi…

GRACE

A. Goodman, A. Taneja, T. Phillips

2024 Updates on Myeloma Precursor Diseases and AL Amyloidosis

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Susanibar-Adaniya

SOHO Italy 2023: Multiple Myeloma Cured in 2030 - What Are the Next …

5th SOHO Italy Annual Conference

K. Anderson

Overview of Pathophysiology, Diagnosis and Management of Multiple My…

University of Colorado Division of Hematology

K. Sidor

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free Light…

Insights from 2023 ASH Annual Meeting

T. Einarsson Long

Hot Off the Press: Experts Discuss the Latest Data in Plasma Cell Dy…

Moffitt Cancer Center

R. Baz, M. Alsina, K. Shain, A. Grajales-Cruz

ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering Multi…

Insights from 2023 ASH Annual Meeting

S. Thorsteinsdottir

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Indy Hematology Review

M. Gertz

Smoldering Multiple Myeloma: Cancer or Condition?

Sigrun Thorsteinsdottir

SOHO Italy 2023: Is It Time for a Biomarkers-Driven Approach in Smol…

5th SOHO Italy Annual Conference

I. Ghobrial